Market Place
Sourcing Support
Forge Biologics Earns My Green Lab Cert Across All Facilities
22 Apr 2026 //
BUSINESSWIRE
Progeria Foundation, Forge Biologics Partner on Gene Therapy
03 Mar 2026 //
BUSINESSWIRE
Ajinomoto CELLiST Launches CELLiSTTM AAV Production Efficiency
02 Feb 2026 //
PHARMIWEB
Ascidian, Forge Biologics Partner on Stargardt Therapy
07 Jan 2026 //
PHARMIWEB
Avista & Forge Announce AAV Develop Manufacturing Partnership
13 Aug 2025 //
BUSINESSWIRE
Forge Biologics partners with Fractyl Health for AAV Development
14 May 2025 //
BUSINESSWIRE
Forge Biologics Announces Eight Presentations at ASGCT Meeting
06 May 2025 //
BUSINESSWIRE
Prolific Machines Appoints Christina as CFO for Commercial Ramp-Up
13 Feb 2025 //
BUSINESSWIRE
Forge Biologics Launches FUEL™ AAV Manufacturing Platform
02 Oct 2024 //
BUSINESSWIRE
Forge Biologics Launches FUEL Manufacturing Platform
02 Oct 2024 //
CONTRACT PHARMA
Forge Biologics Names New CEO
10 Sep 2024 //
CONTRACT PHARMA
Forge Biologics Announces Planned CEO Succession
10 Sep 2024 //
BUSINESSWIRE
Forge Announces 9 Presentations At ASGCT Annual Meeting
30 Apr 2024 //
BUSINESSWIRE
Forge Biologics’ Novel AAV Gene Therapy FBX-101 for Patients with Krabbe Disease
19 Mar 2024 //
BUSINESSWIRE
Forge Biologics Announces Positive FBX-101 Clinical Trial Update
29 Jan 2024 //
BUSINESSWIRE
Forge Biologics Announces Publication in Human Gene Therapy
12 Dec 2023 //
BUSINESSWIRE
New acquisition to support global gene therapy manufacturing
15 Nov 2023 //
EUROPEAN PHARMACEUTICAL REVIEW
CDMO Ajinomoto forges ahead with Forge Biologics in $620M acquisition
13 Nov 2023 //
FIERCE PHARMA
Forge blazes into collaboration to bolster AAV gene therapies
12 Oct 2023 //
FIERCE PHARMA
Forge Biologics Selected as AAV Manufacturing Partner for California Institute
11 Oct 2023 //
BUSINESSWIRE
Forge Biologics to Participate in Multiple September Investor Conferences
05 Sep 2023 //
BUSINESSWIRE
New Hope Research & Forge Announce cGMP Mfg Partnership for Gene Therapy
28 Jun 2023 //
BUSINESSWIRE
Forge Biologics Joins BGTC as Partner to Develop AAV Gene Therapies
23 May 2023 //
BUSINESSWIRE
Forge Biologics Announces Eight Presentations at the ASGCT
11 May 2023 //
BUSINESSWIRE
Forge fires up gene therapy production partnership with Life Bio
09 May 2023 //
FIERCE PHARMA
Life Biosciences, Forge Biologics Partner to Advance Gene Therapies
08 May 2023 //
CONTRACT PHARMA
Forge Biologics and Labcorp partner for gene therapies development
04 May 2023 //
PHARMACEUTICAL TECHNOLOGY
Forge Biologics Partners with Labcorp on AAV Gene Therapy Development
03 May 2023 //
BUSINESSWIRE
Forge Biologics secures manufacturing and development deal with LabCorp
03 May 2023 //
ENDPTS
Forge Biologics Reports Positive FBX-101 Updates for Patients
23 Feb 2023 //
BUSINESSWIRE
Forge Deepens Genetic Medicine CDMO Capabilities with Leadership Team Expansion
25 Jan 2023 //
BUSINESSWIRE
Forge Biologics Receives PRIME Designation from EMA for Novel Gene Therapy
20 Jan 2023 //
CONTRACT PHARMA
Forge Receives Priority Medicines Designation from the EMA for FBX-101
17 Jan 2023 //
BUSINESSWIRE
Forge Biologics to Present at 41st Annual J.P. Morgan Healthcare Conference
04 Jan 2023 //
BUSINESSWIRE
